2 1 Shi Ji Jing Ji Bao Dao·2026-01-29 08:03Core Viewpoint - The Chinese traditional medicine (CTM) industry is undergoing significant regulatory and market changes, leading to a phase of "low-quality" product elimination and industry upgrading as the deadline for new registration regulations approaches [1][2]. Regulatory Changes - The new regulations, effective from July 1, 2026, will require clear safety information on CTM product labels, with products marked as "unclear" facing delisting [1]. - The regulations aim to address the lack of safety information in CTM product labels, which has been a significant issue, with over 40,000 product approvals marked as "unclear" in critical safety areas [3]. Industry Impact - The regulatory countdown is causing a notable impact on the industry, with many companies voluntarily canceling or transferring low-value approvals due to increasing compliance costs [1][4]. - The industry is expected to see a fundamental shift in market dynamics, with a concentration of market share among high-quality enterprises as low-efficiency approvals are eliminated [4][5]. Financial Performance - Recent earnings forecasts indicate a recovery in the CTM sector, with leading companies like Jiangzhong Pharmaceutical and Yiling Pharmaceutical showing significant profit growth due to improved cost management and marketing reforms [7]. - Yiling Pharmaceutical is projected to turn a profit of 1.2 to 1.3 billion yuan in 2025, marking a substantial turnaround from a loss in 2024 [7]. Market Dynamics - The upcoming fourth batch of centralized procurement for CTM is set to further accelerate industry upgrades, with a focus on quality and compliance [8]. - The procurement process will involve a comprehensive evaluation of quality, with strict penalties for non-compliance, ensuring that only high-quality products remain in the market [9]. Future Outlook - The industry is expected to continue moving towards high-quality development over the next 3-5 years, with a focus on modernizing classic formulations and innovating new products [5][6]. - The establishment of a comprehensive quality evaluation system for CTM is crucial for ensuring product efficacy and safety, which will be essential for the industry's global competitiveness [9].